Pavel Petukhov, PhD


Department of Medicinal Chemistry and Pharmacognosy

College of Pharmacy

Research Program

Translational Oncology Program (TO)

Phone: 312-996-4174


Research in Dr. Petukhov laboratory is focused on (1) the discovery, computational design, synthesis, and preclinical studies of novel small molecule compounds as therapeutics for a variety of diseases and conditions and (2) development of novel chemical tools and approaches to study epigenetic “erasers” histone deacetylases (HDACs). Current projects focus on discovery of novel small molecule therapeutics for the treatment of schistosomiasis (TGR, HDAC8), acute myeloid leukemia (HDAC8), chronic hepatitis B virus infections (HDAC5), and migraine (HDAC6).


PhD, Novosibirsk Institute of Organic Chemistry

Disease Focus

Breast; Hematologic; Liver

Research Keywords

Medicinal Chemistry; Computer-aided Drug Design; Virtual Screening; Histone Deacetylase; Photoreactive Probes; Drug Discovery; Thioredoxin Glutathione Reductase; Small Molecule Therapeutics

Additional Language(s)


Published Research

PubMed Search

Other Link(s)

Department Webpage

Translate »